DRK-Blutspendedienst Nord-Ost gGmbH Institut für Transfusionsmedizin Berlin (3210732) - leitarniðurstöður

maxidex augndropar, dreifa 1 mg/ml

novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml

maxitrol augndropar, dreifa

novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa

mydriacyl augndropar, lausn 10 mg/ml

alcon nordic a/s - tropicamidum inn - augndropar, lausn - 10 mg/ml

oculac augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

oculac án rotvarnar augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

oftaquix augndropar, lausn 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn - 5 mg/ml

oftaquix augndropar, lausn í stakskammtaíláti 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn í stakskammtaíláti - 5 mg/ml

opnol augndropar, lausn 1 mg/ml

karo pharma ab* - dexamethasonum fosfat - augndropar, lausn - 1 mg/ml

softacort augndropar, lausn í stakskammtaíláti 3,35 mg/ml

laboratoires thea* - hydrocortisonum natríumfosfat - augndropar, lausn í stakskammtaíláti - 3,35 mg/ml

taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml

santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml